Ugur Sahin - 18 Mar 2026 Form 3/A - Amendment Insider Report for BioNTech SE (BNTX)

Reporting relationship: Chief Executive Officer, 10%+ Owner
Issuer ticker: BNTX
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3/A - Amendment
Accepted by SEC: 13 Apr 2026, 16:02:16 UTC
Original report date: 25 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Humza Bokhari, Attorney-in-Fact

Key filing fact

Ugur Sahin filed Form 3/A - Amendment for BioNTech SE (BNTX) on 13 Apr 2026.

Key facts

This page summarizes Ugur Sahin's Form 3/A - Amendment filing for BioNTech SE (BNTX).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 13 Apr 2026, 16:02.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0002123975 Primary reporting owner

Sahin Ugur

Relationship: Chief Executive Officer, 10%+ Owner
Address: C/O BIONTECH SE, AN DER GOLDGRUBE 12, MAINZ, GERMANY
Signature: /s/ Humza Bokhari, Attorney-in-Fact
Signature date: 13 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BNTX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 39,218,111
Date: 18 Mar 2026
Ownership: See Footnote
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The ordinary shares are held by Medine GmbH. The Reporting Person is the sole shareholder of Medine GmbH. 106,721 of the ordinary shares noted herein are held for the benefit of an individual under a trust arrangement, pursuant to which Medine GmbH exercises voting power, but not dispositive power, over such ordinary shares for so long as such ordinary shares are held in trust. The Reporting Person may be deemed to beneficially own the ordinary shares held by Medine GmbH.

SEC remarks

This Form 3 is being filed to correct the number of shares beneficially owned by the Reporting Person through Medine GmbH, which was inadvertently misreported on the Reporting Person's Form 3 filed on March 25, 2026.